ePrints

Implications for UK practice of the use of durvalumab in stage III NSCLC

Lookup NU author(s): Professor Alastair GreystokeORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Iqbal MS, Atherton P, Macgregor C, Wieczorek A, Singer J, Walther J, Little F, Harden S, Peedell C, Cyriac A, Chowdhury S, Bayne M, Yip K, Britten A, Powell C, Brock J, Datta S, Sevitt T, Mehta A, Greystoke A

Publication type: Article

Publication status: Published

Journal: Annals of Oncology

Year: 2019

Volume: 30

Issue: 2

Pages: ii36-ii36

Online publication date: 24/02/2020

Acceptance date: 02/04/2016

ISSN (print): 0923-7534

ISSN (electronic): 1569-8041

Publisher: Elsevier Ltd

URL: https://doi.org/10.1093/annonc/mdz067.014

DOI: 10.1093/annonc/mdz067.014

Altmetrics

Share